Accessibility Menu
Extendicare logo

Extendicare(OTC) EXETF

Market Cap$2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+731%
5 Year+360%
1 Year+145%
1 Month-10%
$22.69
-0.76%
-0.17Today
Extendicare last closing stock price
MetricPriceDate
Last closeUSD 22.692026-08-31
Extendicare stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.72%USD 22.092026-08-24
1 month-10.12%USD 25.242026-07-31
3 month+4.44%USD 21.732026-06-02
Year to date+47.81%USD 15.352025-12-31
1 year+144.62%USD 9.282025-08-28
3 year+444.09%USD 4.172023-09-01
5 year+359.56%USD 4.942021-09-01
Since inception+730.55%USD 2.732011-10-12

Extendicare Financials at a Glance

Market Cap

$2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$1.98B

Net Income (TTM)

CA$121.38M

EPS (TTM)

$0.95

P/E Ratio

23.67

Dividend

$0.37

Beta (Volatility)

0.24 (Low)

Price

$22.69

Volume

810,566

Open

$22.69

Previous Close

$22.69

Daily Range

$22.69 - $22.69

52-Week Range

$9.34 - $28.45

Estimated Earnings Date

Nov 11, 2026

EXETF News

I’m Buying More Extendicare

Jim RoyalSep 5, 2014

I'm Buying More Extendicare

Jim RoyalDec 11, 2013

I'm Buying Extendicare

Jim RoyalDec 9, 2013

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Extendicare

Extendicare Inc. is a prominent Canadian provider specializing in a comprehensive range of care and support services for seniors. The company operates residential long-term care facilities, retirement living options, and in-home health support services, making it a key player in the healthcare sector.

Products and Services
  • Residential long-term care facilities for seniors
  • In-home health support including nursing and therapy services
  • Consulting and contract services for healthcare organizations
Growth Outlook
  • Expansion of home health care services to meet increasing demand
  • Strategic acquisitions to enhance service offerings and market reach
  • Focus on improving operational efficiencies to drive profitability
Financial Highlights
  • Recent quarterly revenue of CAD 611 million, showing strong growth
  • Trailing twelve months (TTM) net income margin of 6.13%
  • Dividend yield of 1.67%, reflecting commitment to shareholder returns
Extendicare Inc. has established itself as a leader in the healthcare industry, particularly in senior care services. The company's diverse offerings cater to a growing demographic, positioning it well for future growth. Recent financial performance indicates a robust revenue stream, with the latest quarterly results showcasing a significant increase in revenue compared to previous periods. The focus on expanding home health care services aligns with market trends, as the demand for senior care continues to rise. Additionally, the company's commitment to operational efficiency and strategic acquisitions is expected to enhance its competitive edge. With a solid dividend yield, Extendicare Inc. presents an attractive opportunity for investors interested in the healthcare sector.
AI Generated • Aug 31, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

28,000

CEO

Michael R. Guerriere, PhD, MBA

Website

www.extendicare.com

Headquarters

Markham, ON L3R 4T9, CA

EXETF Financials

Key Financial Metrics (TTM)

Gross Margin

39.48%

Operating Margin

8.84%

Net Income Margin

6.13%

Return on Equity

36.33%

Return on Capital

19.32%

Return on Assets

7.79%

Earnings Yield

4.22%

Dividend Yield

1.64%

Payout Ratio

37.58%

Stock Overview

Market Cap

$2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

95.05M

Volume

810.57K

Avg. Volume

145.37K

Financials (TTM)

Gross Profit

CA$624.81M

Operating Income

CA$175.05M

EBITDA

CA$220.16M

Operating Cash Flow

CA$144.45M

Capital Expenditure

-CA$90.37M

Free Cash Flow

CA$54.08M

Cash & ST Invst.

CA$94.67M

Total Debt

CA$646.03M

Extendicare Performance Analysis

Extendicare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 938,336,7720.8%
20232023-12-31CAD 966,859,0083.0%
20242024-12-31CAD 1,070,250,44910.7%
20252025-12-31CAD 1,188,307,15511.0%
Extendicare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3014.8%
Q42025-12-314.9%
Q12026-03-311.0%
Q22026-06-3031.1%
Extendicare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.04N/A
20232023-12-31CAD 0.30N/A
20242024-12-31CAD 0.5894.3%
20252025-12-31CAD 0.8038.4%
Extendicare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-24.3%
Q42025-12-313.6%
Q12026-03-3144.8%
Q22026-06-30-26.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$611.30M

+59.4%

Gross Profit

CA$70.18M

-81.7%

Gross Margin

11.48%

N/A

Market Cap

$2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$91.90K

N/A

Employees

23,500

N/A

Net Income

CA$30.86M

-3.3%

EBITDA

CA$68.36M

+26.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$94.67M

+30.4%

Total Debt

CA$646.03M

+127.4%

Accounts Receivable

CA$159.20M

+64.5%

Inventory

CA$0.00

N/A

Long Term Debt

CA$635.01M

+137.6%

Short Term Debt

CA$11.01M

-34.7%

Return on Assets

7.79%

N/A

Return on Invested Capital

14.92%

N/A

Free Cash Flow

CA$43.88M

+12.4%

Operating Cash Flow

CA$54.26M

+2.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LTGHYLife Healthcare Group Holdings Limited
$2.93+1.63%
WHTCFWELL Health Technologies Corp.
$3.16+0.00%
GNMLFGenomma Lab Internacional, S.A.B. de C.V.
$0.78-5.13%
PHCIPanamera Holdings Corporation
$2.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About EXETF

What is the current price of Extendicare?

Extendicare is trading at $22.69 per share.

What is the 52-week range for Extendicare?

Over the past 52 weeks, Extendicare has traded between $9.34 and $28.45.

How much debt does Extendicare have?

As of the most recent reporting period, Extendicare reported total debt of CA$455.15M.

How much cash does Extendicare have on hand?

Extendicare reported CA$66.70M in cash and cash equivalents in its most recent financial results.

What is Extendicare’s dividend yield?

Extendicare currently has a dividend yield of 1.64%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services